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ABSTRACT 
 Cellular communication occurs as a result of changes in signaling pathways.  
A well-studied signaling pathway is through G protein coupled receptors (GPCRs).  
In gonadotropes, GPCR stimulation by GnRH leads to the activation of protein kinase 
A (PKA).  Activated PKA can phosphorylate ion channels, potentially causing an 
influx of calcium, depolarization and secretion of hormones.  A scaffolding protein 
known as AKAP150 anchors PKA near L-type calcium channels.  In addition, 
AKAP150 anchors phosphatases, which provides temporal control during signaling 
events.  It was recently shown that AKAP150 is mobile in neuronal dendrites, 
providing regulation to where the signaling cascade occurs in the cell.   It is not yet 
known what AKAP150 binds to in gonadotropes or how it translocates.  In order to 
investigate the mobility of this protein in pituitary cells, a variety of methods were 
used in this study.  Time-lapse imaging and permeabilization assays suggested that 
AKAP150-GFP was mobile in LβT2 cells, but more sensitive methods were needed 
to study temporal and spatial resolution.  Quantitative FRAP and FLIP analysis 
provided strong qualitative evidence that AKAP150-GFP was mobile in LβT2 cells 
and the protein moved laterally along the cell rim.  Lastly, comparing rim intensity in 
LβT2 cells immunostained for endogenous AKAP150 and actin indicated the 
scaffolding protein could cluster with to actin.   
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Basic Hormone Function 
One role of the endocrine system in the human body is to maintain body 
homeostasis by signaling through hormones.  Hormones are chemical signals that 
help to coordinate the body’s functions.  When released from a cell, peptide 
hormones are secreted into the blood stream and control long lasting responses to 
stimuli in the body.   Examples of stimuli affecting the endocrine system include 
dehydration, low blood glucose levels and an increase in heart rate and stress when 
feeling threatened (Yeung et al. 2006).  In addition to regulating the response to 
specific stimuli, hormones control developmental processes such as distinct sex-
driven appearances between adult males and females.  Several disease states exist due 
to an imbalance of hormones.  A few of these diseases include diabetes mellitus, 
hypopituitarism, Cushing syndrome and Graves’ disease.  Peptide hormones are 
composed of protein, peptides, or amines and are compacted in dense core vesicles 
before being released into the blood stream.  Such hormones are soluble in water and 
are unable to pass through the cell membrane, thus requiring binding to a receptor on 
the outside of the cell to relay the signal to inside of the cell (Yeung et al. 2006). 
A structure in the brain that controls the pituitary endocrine system is the 
hypothalamus.  The hypothalamus receives signals from external and internal stimuli 
before sending out neuronal or hormonal responses.  The hypothalamus affects the 
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endocrine system by directly stimulating or inhibiting the pituitary gland.  The 
pituitary gland is composed of an anterior and posterior lobe.  The anterior lobe 
contains endocrine cells and the posterior lobe is composed of nervous tissue and is 
considered an extension of the hypothalamus (Davis et al. 2013).  The hypothalamus 
controls the anterior pituitary by using releasing and inhibiting hormones.  The 
releasing hormones stimulate the anterior pituitary to secrete one or more specific 
hormones.  The inhibiting hormones induce the anterior pituitary to stop secreting one 
or more specific hormones (Yeung et al. 2006).      
The anterior lobe of the pituitary is composed of five different endocrine cell 
types that secrete hormones necessary for growth, development, metabolism and 
sexual function.  These cell types include thyrotropes, lactotropes, corticotropes, 
somatotropes and gonadotropes (Ooi, Tawadros, and Escalona 2004).   These cells 
secrete hormones directly into the blood, which control the activity of other endocrine 
glands and tissues.  
Gonadotropes make up approximately 10-15% of the cell population in the 
anterior pituitary and secrete the gonadotropin hormones, leutinizing hormone (LH) 
and follicle-stimulating hormone (FSH).  Gonadotropin secretion occurs when 
gonadotropin-releasing hormone (GnRH), binds to a GnRH- receptor, causing an 
increase in cytosolic calcium and secretion of LH and FSH (Ooi, Tawadros, and 
Escalona 2004).  LH and FSH affect reproduction function by acting on the gonads.  
Once stimulated by LH or FSH, the ovaries and testes can then synthesize and secrete 
estrogens, progestins and androgens (Yeung et al. 2006).  
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LβT2 Gonadotrope cell line 
In order to study gonadotropes as an isolated cell, several gonadotroph cell 
lines have been created.  The present research study utilized the LβT2 immortalized 
cell line.  The LβT2 cell line was created from pituitary tumors that developed in a 
transgenic mouse using the SV 40 T-antigen driven by the rat LHβ gene promoter.  
This cell line is considered an acceptable gonadotroph model because it expresses 
mRNA for both LHα and LHβ subunits, which are markers of gonadotrope 
differentiation (Ooi, Tawadros, and Escalona 2004).  In addition, LβT2 cells express 
mRNA for the GnRH receptor and secrete LH when GnRH is bound to the GnRH 
receptor (Thomas et al. 1996).   In addition, LH secretion is stimulated by 
depolarization of these cells, which is another indicator of the cell responding in a 
normal physiological manner.   
In LβT2 cells, the GnRH receptor is a plasma membrane G protein coupled 
receptor (GPCR) that interacts with heterotrimeric G proteins to initiate downstream 
signaling (Liu et al. 2002).  After the GTP-bound α subunit is released from the βδ 
subunits of the heterotrimeric G protein, several second messenger signaling 
molecules are activated.  These molecules create an increase in intracellular 
diacylglycerol (DAG) and calcium from phosphoinositide turnover as well as an 
increase in intracellular cyclic adenosine monophosphate (cAMP) levels.  The second 
messenger molecules then activate down-stream kinases, such as protein kinase C 
(PKC), protein kinase A (PKA), and calcium-dependent kinases (Liu et al. 2002).  
Specifically, GnRH activates the ERK, c-Jun N-terminal and p38 MAPK families in 
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LBetaT2 cells.  GnRH also induces c-fos and LHβ protein expression in this cell line 
(Liu et al. 2002).  The stimulatory G proteins coupled to the GPCR when activated by 
GnRH in LBetaT2 cells are Gαq/11 and Gαs.   To verify that these proteins were 
activated in LBetaT2 cells, recombinant adenovirus vectors expressing Gαq wildtype 
or a constitutively active mutant (Q209L) Gαq were used to analyze for increased 
ERK, c-Fos and LHβ protein expression.  In the cells containing the constitutively 
active mutant, c-Fos and LHβ protein expression was induced, but ERK was not.  The 
lack of ERK can be attributed to the protein becoming inactivated before expression 
could be detected.  In addition, several peptides were created to specifically block 
Gαq, Gαs and Gβδ when measuring phospho-ERK expression in LβT2 cells after 
treatment with GnRH.   The peptides successfully inhibited phospho-ERK expression 
by blocking Gαq and Gαs, but not Gβδ, indicating that signaling is occurring through 
Gαq and Gαs. (Liu et al.).  The G protein coupled receptor does not activate Gαi/o.  This 
was examined by blotting for phosphorylated ERK after treating the cells with 
pertussis toxin, a chemical known to stimulate Gαi.  After treatment with pertussis 
toxin, LBetaT2 cells did not show increased levels of phosphorylated ERK compared 
to control cells (Liu et al. 2002).    
 
 
Basic Cellular Communication 
 
Cellular communication is essential in multicellular organisms to coordinate 
activities for survival and growth.  In order to communicate, cells must interpret 
extracellular ligands using receptors that form an intracellular protein cascade, which 
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creates the necessary cellular response.  Examples of effector protein targets include 
gene regulatory proteins, ion channels, components of a metabolic pathway and 
cytoskeletal components (Hall and Lefkowitz 2002).  By using extracellular signals 
for communication, this allows the cell to interact with other cells either nearby or far 
away in the organism.   Endocrine cells secrete hormones into the blood stream to 
signal to other cells.  Secreting hormones into the blood stream allows the endocrine 
cell to communicate with cells either nearby or very far away in the body.   
In order for a cell to receive a signal, it must contain a receptor that recognizes 
the signal.   Signaling ligands include proteins, small peptides, amino acids, and 
nucleotides (Kobilka 2007).  Once an extracellular receptor has been activated, the 
signal is relayed through the cell by using small molecules and intracellular signaling 
proteins.  Three of the most common small molecules include cyclic AMP (cAMP), 
calcium (Ca+2) and diacylglycerol (DAG).   These small signaling molecules help to 
relay the signal by binding to and altering the conformation or behavior of proteins 
involved in the signaling cascade.  The proteins involved in the signaling cascade are 
usually intracellular proteins and help to progress or stop the signal by creating 
intermediate signaling molecules or changing the conformation of proteins in the 
signaling cascade (Brogi et al. 2014).  The rate at which the changes are made in the 
cell receiving the signal vary depending on the desired outcome of the message 
received.  Phosphorylation of a protein that is already in the cell occurs quickly while 
creation of a new protein or molecule through transcription and translation can take 
longer (Alberts, B. Johnson, A. Lewis, J. Raff, M. Roberts, K. Walter 2008).     
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G Protein Coupled Receptors 
In many cells, messages are relayed from the extracellular space to the 
cytoplasm through G-protein coupled receptors (GPCRs).  The function of activated 
GPCRs is to stimulate or inhibit other proteins in a signal transduction cascade or 
regulate an ion channel.  The signals that the receptor receives include hormones, 
neurotransmitters, and local mediators.  G protein coupled receptors are important to 
understand in the context of cell signaling because half of all known drugs work 
through these receptors (Alberts, B. Johnson, A. Lewis, J. Raff, M. Roberts, K. 
Walter 2008).  GPCRs are a transmembrane protein that spans through the membrane 
seven times and is coupled with a trimeric GTP-binding protein.  The GTP-binding 
protein is composed of alpha, beta and gamma subunits.  In an inactive state, the 
alpha subunit has GDP bound to it and the subunits are congregated together.  In an 
activated state, the alpha subunit dissociates from the trimeric protein and has GTP 
bound to it.  There are several different isoforms of the alpha subunit, some of which 
are stimulatory and some of which are inhibitory (Alberts, B. Johnson, A. Lewis, J. 
Raff, M. Roberts, K. Walter 2008).     
In LBetaT2 cells, the purpose of signaling through a GPCR is to increase the 
amount of cyclic AMP (cAMP) in order to activate protein kinase A (PKA).  When 
the extracellular portion of the receptor binds a ligand, the receptor undergoes a 
conformational change, which allows it to activate the G protein, releasing the alpha 
subunit bound to GTP.  The stimulated G alpha subunit then activates adenylyl 
cyclase (AC), another transmembrane protein.  Adenylyl cyclase synthesizes cAMP 
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from ATP. The cAMP then binds to PKA in order to activate serine/threonine kinases 




























Figure 1:  Signaling cascade leading to the activation of protein kinase A.  When the 
hormone GnRH, binds to the GnRH receptor, the α subunit of the trimeric GTP 
binding protein, becomes activated and dissociates from the βδ subunits.  The GTP-
bound α subunit activates adenylyl cyclase, leading to an increased concentration of 
intracellular cAMP.  The increased concentration of cAMP activates PKA, which can 
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Protein Kinase A 
Protein Kinase A, or PKA, is an enzyme that regulates many biological 
processes and is associated with disease due to insufficient or inappropriate 
phosphorylation (Taylor et al. 2012).  Protein Kinase A is a holoenzyme consisting of 
two regulatory subunits and two catalytic subunits.  The regulatory subunits include 
RIα, RIβ, RIIα and RIIβ.  The different catalytic subunits include Cα, β, and δ 
(Dell’Acqua and Scott 1997).   The regulatory and catalytic subunit isoforms allow 
for the formation of different isoforms of the holoenzyme, which bind to specific 
subcellular locations in the cell.  PKA I is primarily found in the cytoplasm where as 
PKA II is targeted mainly to subcellular structures (Taskén and Aandahl 2004).  The 
regulatory subunits each contain two binding sites for cAMP.  The two sites on the 
regulatory subunit where cAMP can bind are the A site and B site.  cAMP binds to 
the B site first and then the A site (Taskén and Aandahl 2004).  When cAMP is not 
bound to the regulatory subunits the enzyme is inactive.  Once the cAMP has bound 
to the regulatory subunits, then the catalytic subunits are released from the 
holoenzyme and are free to phosphorylate on serine or threonine residues on several 
different protein substrates (Taskén and Aandahl 2004).  Phosphorylation of serine or 
threonine residues on specific proteins induce conformational changes that activate or 
inhibit cellular processes.  In cardiac cells, phosphorylation of L-type calcium 
channels by PKA enhances the influx of calcium and depolarization of the cell (Gao 
et al. 1997).  In gonadotrophs, phosphorylation and enhanced opening of ion channels 
could lead to increased calcium influx, depolarization and secretion of hormones 
(Dell’Acqua and Scott 1997).  





Figure 2: A model demonstrating the activation of protein kinase A.  Protein kinase A 
is a holoenzyme consisting of two regulatory (R) subunits and two catalytic (C) 
subunits.  In an inactive state, cAMP is not bound to the holoenzyme.  In an activated 
state, the regulatory subunits bind cAMP and the catalytic subunits dissociate from 
the regulatory subunits.  The catalytic subunits can then phosphorylate threonine and 
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AKAP150 
A Kinase Anchoring Proteins (AKAPs) are scaffolding proteins that can bind 
both kinases and phosphatases.  By localizing kinases and phosphatases in close 
proximity to each other allows for greater temporal control in signaling cascades 
(Dai, Hall, and Hell 2009).  AKAP150 is one of the most studied anchoring proteins 
in neuronal and cardiac cells.  AKAP150 is expressed in mice and has two orthologs: 
AKAP75 in bovine and AKAP79 in humans (Tunquist et al. 2008).  The enzymes 
most commonly bound to AKAP150 are PKA, calcium/phospholipid-dependent 
protein kinase C (PKC) and calcium/calmodulin-dependent protein phosphatase 2B 
(PP2B).  Each of the enzymes is inhibited when bound to the AKAP and requires 
specific second messenger signals to activate the enzymes.  The scaffolding complex 
is tethered to the interior of the plasma membrane where its binding partner can 
respond to second messengers, such as cAMP, calcium, and phospholipids.  When 
bound to the interior of the plasma membrane, the AKAP 150 family of proteins 
controls phosphorylation of ion channels such as AMPA-type glutamate receptors, L-
type calcium channels, aquaporin water channels and M-type potassium channels 
(Hoshi, Langeberg, and Scott 2005).  By anchoring signaling enzymes in such close 
proximity, enzyme regulation can be partially controlled by negative feedback loops.  
For example, in addition to phosphorylating substrates, increased PKA activity 
activates PP2B, which dephosphorylates the substrate targeted by PKA.  In neurons, 
AKAP 150 is targeted to post-synaptic densities (Hoshi, Langeberg, and Scott 2005).  
The post-synaptic substrates include α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors, calcium channels and N-Methyl-D-
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aspartic acid (NMDA) receptors in hippocampal synapses (Taskén and Aandahl 
2004).  In studies involving Human Embryonic Kidney (HEK) cells and native 
cardiac myoctes, it was shown that PKA anchored to AKAP150 is necessary for the 
phosphorylation of α1C subunits in maintaining an open state of L-type calcium 
channels (Gao et al. 1997).  In cardiac myocytes, stimulation of L-type calcium 
channels by β-adrenergic agonists occurs through a cAMP and PKA-dependent 
pathway.  Disruption of this pathway by blocking the ability of PKA to bind to 
AKAP150 results in reduced calcium channel currents (Gao et al. 1997).  In addition 
to anchoring PKA, PKC and PP2B, it has been proposed that AKAP150 interacts 
with F-actin, phosphatidylinositol-4,5-bisphosphate (PIP2) and cadherin complexes to 
anchor the protein in post synaptic densities in neurons. This has been proposed 
because the scaffold has been shown to be disrupted by actin polymerization 
inhibitors (Dell’Acqua et al. 2006).   Due to the unknown nature of what AKAP150 is 
binding to, there is not much information about how the protein translocates.  The aim 
of my thesis is to generate more knowledge about the binding and translocation of 
AKAP150 in anterior pituitary cells. 
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Figure 3: AKAP150 scaffolding protein model.  The three most common enzymes 
attached to the AKAP150 scaffolding protein are protein kinase A (PKA), protein 
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Intent of Thesis 
 
 The goal of this thesis is to study the dynamics of AKAP150 in anterior 
pituitary cells.  AKAP150 is dynamic protein in the dendritic spines of neuronal cells: 
AKAP150 can bind lipids in the cell membrane and actin in the cytoskeleton 
(Dell’Acqua et al. 2006).  However how the protein translocates and what causes it to 
translocate is currently not known.  Previous preliminary experiments conducted in 
the Angleson lab suggest cortical localization of AKAP150 in endocrine cells 
changes with treatment of pharmacological agents.  We investigated these changes 
using time-lapse imaging, FRAP, FLIP, and immunostaining assays.  During this 
process, we also demonstrated method development for analyzing quantitative FRAP 
data.  Using these methods allowed us to learn more about the dynamics of AKAP150 
















MATERIALS AND METHODS 
Cell Culture 
LBetaT2 cells from Pamela Mellon (University of California, San Diego) 
were cultured in DMEM media containing 25mM glucose (Cellgro), 1% sodium 
pyruvate (Cellgro), 10% fetal bovine serum (Valley Biomedical), 1% of a 
penicillin/streptomyocin solution (10,000 IU/mL Penicillin, 10,000 ug/mL 
Streptomyocin, Cellgro) and 1.85g sodium bicarbonate (Fisher Scientific).  All 
ingredients were mixed together and brought up to 500mL with nanopure water.  The 
media was sterilize filtered with a 0.45µm filter (Cell treat).  The cells were 
maintained in a humidified incubator with 95% air, 5% CO2 at 37°C.  The cells were 
split approximately once every seven to ten days. 
The 5mM K+ standard external resting solution used during experiments 
contained 1mM MgCl2, 10mM HEPES, 5mM CaCl2, 137mM NaCl, 5mM KCl and 
10mM D-glucose (pH 7.2).  The high potassium solution contained 1mM MgCl2, 




 Chamber slides were coated with 250µL ECL (EMD Millipore), a cell 
adhesion matrix, and incubated at 37°C for 90 minutes.  Media was removed from a 
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flask containing LβT2 cells and pipetted into a 50mL conical tube.  5ml trypsin 
(Corning) was added to flask for three minutes.  Each side of the flask was washed 
with trypsin and then trypsin was pipetted into the bottom several times to break up 
clumps of cells.  The cells (and trypsin) were added to the 50mL conical and 
centrifuged at 5000rpm for 10 minutes.  The supernatant was removed from the cell 
pellet and LβT2 media was used to re-suspend the cells.  ECL was removed from the 
chamber slides and 500µL of cells were added to each chamber.  Cells were 
incubated at 37°C for 45 minutes. 
 
Plasmid Preps 
 The AKAP150-GFP plasmid (gift from Mark Dell’Acqua) was isolated using 
competent DH5α E. coli cells (Invitrogen).  AKAP150-GFP (1µL) plasmid was 
added to chilled DH5α cells (100µL) and incubated on ice for 30 minutes.  The cells 
were heat shocked at 42°C for 50 seconds and then incubated on ice for two minutes.  
S.O.C. media (900µL) (Invitrogen) was added to the cells and shaken at 225rpm for 1 
hour at 37°C.  Transformed cells (10µL) were added to 990µL S.O.C. media 
(Invitrogen) and 100µL of that solution was spread on a LB plate containing 
kanamycin.  The plate was incubated overnight at 37°C.  One colony was removed on 
a plate with a 200mL pipette tip and added to LB broth (110mL) containing 110µL 
kanamycin (50mg/mL).  The flask was shaken overnight at 37°C at 300rpm.  A 
Qiagen maxi plasmid prep kit was used for eluting plasmid from E. coli.  The plasmid 
(1µg/µL) was diluted with endotoxin-free TE Buffer. 
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Transfection of LβT2 Cells 
 Glass bottom dishes (17mm thick, Wellco) were coated with ECL (300µL) 
and put in incubator at 37°C for 1 hour.  Opti-Mem or TransfectaGro (1mL) was 
warmed to room temperature in a 37°C water bath.  Opti-MEM (200µL) was pipetted 
into a 1.5mL tube labeled A and into a 1.5mL tube label B. Lipofectamine Reagent 
2000 (2µL) was added to tube A.  2µL endotoxin-free AKAP150-GFP plasmid 
(1405.2ng/µL) was added to tube B.  The reactions incubated at room temperature for 
5 minutes.  Tube A was added to tube B and the reaction was incubated at room 
temperature for 20 minutes.  Media was pipetted from the flask and placed in a 50mL 
centrifuge tube.  Cells were treated with trypsin for three minutes.  Each side of the 
flask was washed with trypsin and then trypsin was pipetted into the bottom several 
times to break up clumps of cells.  Cells (and trypsin) were centrifuged at 5000rpm 
for 10 minutes and supernatant was removed from the cell pellet.  Cells were re-
suspended in Opti-Mem (100µL).  ECL was removed from the glass bottom dishes 
and re-suspended cells (25µL) were added to each dish.  100µL from the tube 
containing lipofectamine, Opti-MEM and plasmid was added to the cells on the glass 
bottom dish.  The glass bottom dishes were incubated for three hours in an incubator 
at 37°C and containing 95% air and 5% CO2..  LβT2 media (2mL) was added to each 
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Time-lapse Imaging Assay 
 Perfusion assays were performed using a gravity flow system.  One image was 
taken every 30 seconds for approximately 10 minutes (20 time points).  Perfusion 
solutions contained either a standard external solution or the standard resting solution 
with a pharmacological agent, added as indicated.  The standard resting solution was 
5mM K+/10mM glucose.  The starting solution for LβT2 cells transfected with 
AKAP150-GFP plasmid was the standard external solution.  LβT2 cells transfected 
with AKAP150-GFP were perfused with the standard resting solution for the first two 
minutes of data collection.  Immediately after two minutes, the solution was switched 
from resting solution to the solution containing a pharmacological agent for 30-60 
seconds.  After 30-60 seconds, the drug solution was turned off, and the cells were 
bathed in the solution containing a pharmacological agent for the remainder of the 
imaging.  The intensities of the cell surface (‘rim’) were determined by subtracting a 
mask created by background signal from a mask created around the rim of a cell.   
 
Permeabilization Assay 
 Chamber slides (Nalge Nunc International) were coated with ECL (250µL) 
and incubated at 37°C for 90 minutes.  ECL was removed from slides and 500µL of 
LβT2 cells transfected with AKAP150-GFP were added to each chamber.  Cells on 
chamber slides were incubated at 37°C for 45 minutes.  The media was removed, and 
the cells were washed three times with phosphate buffered saline solution (PBS).   A 
4% paraformaldehyde (PFA) solution (Electron Microscopy Solutions) was added to 
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the cells for 15 minutes.  The PFA solution was removed, and the cells were washed 
three times with PBS.  To permeabilize cell membranes, a 0.4% Triton X-100 (Fisher 
Scientific) solution was added to the cells for 15 minutes.  The Triton X-100 solution 
was removed, and the cells were washed three times with PBS.  The chambers were 
removed from the slides and one drop of Vectashield with DAPI (Vector 
Laboratories, Inc.) was added to each space containing cells.  Glass coverslips (Fisher 
Scientific, 18x18-3) were placed on top of the Vectashield and secured in place using 
clear nail polish.  The intensities of the cell surface (‘rim’) were determined by 
subtracting a mask created by background signal from a mask created around the rim 
of a cell.  For ‘intact cell’ preparation, permeabilization with Triton X-100 was 
omitted.   
 
Immunostaining 
 LβT2 cells were plated on chamber slides.  The media was removed and the 
cells were washed three times with PBS.  A 4% paraformaldehyde (PFA) solution 
(Electron Microscopy Solutions) was added to the cells for 15 minutes.  The PFA 
solution was removed, and the cells were washed three times with PBS.  A 0.4% 
Triton X-100 solution was added to the cells for 15 minutes.  The cells were washed 
three times with PBS.  A 1:100 primary antibody solution was made with AKAP150 
primary antibody (Goat anti-AKAP150, Santa Cruz Biotechnology, Catalog #: SC-
6445) and blocking solution, normal donkey serum.  The cells were incubated with 
the primary antibody solution at 37°C for 90 minutes in a humidifying chamber.  The 
antibody was removed, and the cells were washed three times with PBS.  A 1:800 
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secondary antibody solution (Alexa 488 anti-goat, Invitrogen) was made by pipetting 
secondary antibody into blocking solution with normal donkey serum.  The cells were 
incubated with the secondary antibody solution at 37°C for 45 minutes in a 
humidifying chamber.   The cells were washed three times with PBS.  The chambers 
were removed from the slides, and one drop of Vectashield with DAPI was added to 
each space containing cells.  Glass coverslips were secured in place using clear nail 
polish.  In the cell containing drug treatment, the pharmacological agents were added 
for five minutes.  The pharmacological agents were added after the media was 
removed, but before fixing the cells.  In order to analyze endogenous AKAP150 and 
actin together, Alexa 568 phalloidin was added to the cells after the secondary 
antibody, and then the cells were incubated for 20 minutes in a humidifying chamber.    
 
Fluorescence Microscopy 
 Fluorescence microscopy was performed using an inverted Zeiss Axiovert 
S100 TV microscope and recorded with Slidebook version 6.0 digital microscopy 
software.  Images were acquired with 40x objective (N.A. 1.30).  In the Slidebook 
software, images were viewed in the focus window with 40x oil objective, exposure 
of 1000ms, filter set to Live and the green Live filter was used.  Images were acquired 
in the capture window with bin factor 1x1 and time lapse.  
 
Confocal Microscopy 
 Confocal microscopy was performed using a laser scanning Olympus 
FluoView FV1000.  Fluorescence Recovery After Photobleaching (FRAP) was done 
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on single LβT2 cells transfected with AKAP150-GFP using the Fluoview SIM 
scanner with Olympus Fluoview Ver 4.1 software.  550 images were acquired for 
each video using the 60x objective (N.A. 1.42) and Main Scanner Sync in Fluoview.  
The images of the cells were acquired using 5% laser transmission at wavelength 488 
and the EGFP filter.  The cells were photo bleached using 100% laser transmission at 
wavelength 488 and the EGFP filter.  The tornado or rectangle tool was used to draw 
the region of interest (ROI) on the cell.   Brightfield images were taken using 5% 
laser transmission at wavelength 488 and TD1 filter.  Before imaging either cell type, 
media was removed and replaced with 5mM K+ standard external resting solution. 
 Translocation of AKAP150-GFP was measured by creating recovery curves at 
the right, middle and left edges of the ROIs on the rim during photobleaching.  When 
photobleaching using the baseline parameters, 0.5 microns were measured outside of 
the left and right edges of the ROI.  0.25 microns were measured on either side of the 
median in the middle of the ROI.  When photobleaching using the fast rectangular 
and tornado parameters, 0.5 microns were measured outside of the left and right 
edges of the ROIs on the rim during photobleaching.  0.25 microns were measured on 
either side of the median in the middle of the ROI. 
 Confocal microscopy was performed on LβT2 single cells immunostained 
with anti-AKAP150 and phalloidin.  AKAP150 was imaged with the Alexa 488 laser 
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FRAP Analysis 
Baseline parameters: A total of 300 frames were acquired at a frame rate of 
1.11 seconds per frame for a total time of approximately 5.5 minutes.  The 
rectangular ROI was bleached for 5 seconds at a speed of 100µs per pixel using 100% 
transmission of the 488 laser.  The image was acquired using an aspect ratio of 
512x512 at a speed of 12.5µs per pixel.  The main scanner sync was used to collect 
images. 10 frames were taken before photobleaching.  Images were acquired for 11 
seconds, photobleached for 5 seconds and captured the recovery for 5.2 minutes. 
Fast Rectangle parameters: A total of 550 images were acquired at a frame 
rate of 0.3 seconds per frame for a total time of approximately 2.75 minutes.  The 
ROI was photobleached for either one second or 2.5 seconds at a speed of 100µs per 
pixel using 100% transmission of the 488 laser.  Images were acquired using an 
aspect ratio of 128x128 at a speed of 2µs per pixel.  The main scanner sync was used 
to collect images.  30 frames were taken before photobleaching.  A rectangle ROI 
(13x49) was used in each experiment and positioned vertically around the cell rim.  
Images were acquired for 9 seconds, photobleached for either 0.3 seconds or 0.75 
seconds and captured the recovery for approximately 2.5 minutes. 
Fast tornado parameters: A total of 550 images were acquired at a frame rate 
of 0.3 seconds per frame for a total time of approximately 2.75 seconds.  The ROI 
was photobleached for either one second or 2.5 seconds at a speed of 100µs per pixel 
using 100% transmission of the 488 laser.  Images were acquired using an aspect ratio 
of 128x128 at a speed of 2µs per pixel.  The main scanner sync was used to collect 
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images.  30 frames were acquired before photobleaching.  A tornado ROI (22x22) 
was used in each experiment.  Images were acquired for 9 seconds, photobleached for 
either 0.3 seconds or 0.75 seconds and captured the recovery for approximately 2.5 
minutes.   
 Quantitative FRAP analysis was provided by Dr. Dinah Loerke and Roopa 
Madhu.  Watershed analysis was used to define the rim of the cell and MATLAB was 
used to generate rim intensity.  Rim intensity in the heat maps was calculated by 
dividing intensity at a point in time by the pre-bleach intensity.  A red color indicates 




 Slidebook Version 6.0 was used to create masks to analyze rim brightness in 
the time-lapse imaging, permeabilization, and immunostaining assays.  Kaleidograph 
was used to create dot plots and run statistical analyses.  Wilcoxon-Rank-Sum tests 
were used on non-normal distributions.  Student’s t-tests were run on normal 
distributions. Statistical significance was considered at p<0.05.  Where indicated, data 
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A type I and 









cyclase  50µM  20mM Ethanol 
Jasplakinolide 
 Induces actin 
polymerization 
and 
stabilization  3µM  705mM   DMSO 
Lantrunculin 
A 
 Inhibits actin 
polymerization  1µM  237mM  Ethanol 
     
Table 1: Pharmacological agents used during experimental procedures.  A brief 













 N6-Benzoyladenosine-3',5'-cyclic monophosphate 
sodium salt 
Forskolin 
 (3R, 4aR, 5S, 6S, 6aS, 10S, 10aR, 10bS)- 6, 10, 
10b- trihydroxy- 3, 4a, 7, 7, 10a- pentamethyl- 1- 
oxo- 3- vinyldodecahydro- 1H- benzo[f] chromen- 


















Monophosphorothioate, Rp-isomer sodium salt 
Table 2: Abbreviations Nomenclature.  An abbreviated nomenclature is provided for 


















Effects of pharmacological agents on transfected LβT2 cells 
 The first set of experiments focused on rim intensity changes during confocal 
imaging of live imaging in LβT2 cells transfected with AKAP150-GFP.  In LβT2 
cells, AKAP150 protein localizes to the cell rim.  The purpose of these experiments 
was to determine if AKAP150-GFP is mobile upon the introduction of specific 
pharmacological agents in solution.  
 
Time-lapse Imaging of Transfected LβT2 Cells  
The time-lapse imaging assays were performed by collecting one image every 
30 seconds for approximately 10 minutes (20 time points).  When collecting the live-
cell data from time-lapse imaging, the change of rim brightness was plotted in a graph 
displaying intensity over time(s).  One image was taken every 30 seconds to minimize 
unintended photobleaching.  The experiment began with cells in the standard resting 
solution for two minutes  (four control time points) and then switched to a resting 
solution with a pharmacological agent. The control cell maintained constant rim 
fluorescence intensity, verifying that unintended photobleaching was not causing a 
decrease in rim intensity.   In Figures 4B-4D, where the pharmacological agents 
activated or inhibited PKA, the cells treated with rp8-cpt-cAMPs and forskolin 
showed a trend in decreasing fluorescence intensity, but the cell treated with 6-
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benzoyl-cAMP did not.  In Figures 4E-4F, where the pharmacological agents 
activated PKC and caused an increase in Ca+2, the cells treated with both PMA and 
100mM K+ showed a trend of decreasing fluorescence.  Lastly, in Figures 4G-4H, 
where the pharmacological agents stabilized or inhibited actin polymerization, the 
cells treated with jasplakinolide and lantrunculin A showed a minimal decrease in 
fluorescence intensity.  The results of experiments with PMA were promising because 
they indicated the translocation of AKAP150-GFP.  It is possible that we did not 
observe a significant decrease in fluorescence intensity in the cells treated with the 
pharmacological agents other than PMA because AKAP150-GFP was translocating 
laterally.  The trend in decreased fluorescence suggested possible translocation from 
the rim to the cytosol.  Lateral translocation only of AKAP150-GFP would not cause 
a significant decrease in fluorescence intensity.   We decided we needed a more 
sensitive method to study the translocation of AKAP150-GFP in anterior pituitary 
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Figure 4:  Mobility of AKAP150-GFP in time-lapse imaging assays.  In each of the 
assays, LβT2 cells transfected with AKAP150-GFP were imaged once every 30 
seconds for 10 minutes (20 time points).  For the first two minutes (four time points), 
cells were bathed in standard resting solution and then switched to a resting solution 
containing a pharmacological agent.  (A) Control  (B) Rp-8-cpt-cAMPs (C) 6-
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Fluorescence Recovery After Photobleaching (FRAP) on LβT2 Cells 
Transfected with AKAP150-GFP 
 
To focus further on the translocation of AKAP150 in LβT2 cells, we tested 
the mobility of the scaffolding protein by measuring recovery of AKAP150-GFP after 
photobleaching.  FRAP would provide a more sensitive method to test the mobility of 
AKAP150-GFP.  It is predicted the recovery of AKAP150-GFP could translocate 
from the rim, cytosol or both.  It is unknown how the scaffolding protein moves 
within the cell, for example diffusing freely or binding to a structure, such as actin.  
Previous in vitro studies have suggested that AKAP150 attaches directly to both the 
actin cytoskeleton and lipids in the membrane (Dell’Acqua et al. 2006).  
 
Fluorescence Recovery After Photobleaching in LβT2 Cells 
 In order to study AKAP150-GFP mobility using a more sensitive method, we 
analyzed quantitative FRAP data.  Baseline parameters were established for the 
FRAP imaging.  The ROI appears to almost be completely photobleached at frame 
13, which is about 3.3 seconds into the 5-second photobleach.  Recovery is not 
apparent in the photobleached area at 5.5 seconds post-photobleach.  A very dim rim 
is visible at 27.5 seconds post-photobleach.  The rim is visible at both 159.5 and 
324.5 seconds post-photobleach.  Although the fluorescence of the rim recovers 
following photobleach, it did not appear as bright as the rim pre-photobleach.  This 
FRAP data indicate that AKAP150-GFP in LβT2 cells is mobile. 
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Figure 5: Fluorescence Recovery After Photobleaching (FRAP) of an LβT2 cell 
transfected with AKAP150-GFP.  Cells were imaged on a laser scanning confocal 
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Hypothetical Schematics of Recovery from FRAP 
 In order to visualize the origin of the recovered AKAP150-GFP in the cell, we 
created a post-photobleaching recovery model (Figure 7).  Cell A shows the recovery 
of AKAP150-GFP expression originating from a cytosolic pool of AKAP150 only.  
Recovery from the cytosol would be considered rapid because every area along the 
rim that was photobleached has access to the soluble, cytosolic pool of AKAP150-
GFP.  Cell B shows recovery due to the lateral movement of AKAP150-GFP at the 
rim only.  Recovery along the rim is expected to take longer because the protein must 
move a greater distance (laterally from the outside of the bleached area to the middle 
of the ROI).  The green arrows above cell B show Fluorescence Loss in 
Photobleaching (FLIP) from the region outside of the ROI.  We expect this to occur 
as AKAP150-GFP translocates to the inside of the ROI to aid in recovery.  Cell C 
shows recovery of expression due to movement of AKAP150-GFP from both the rim 
and cytosol.  Similar to Cell B, a combination of cytosolic and lateral translocation 
would also show FLIP in the region outside of the ROI.  The difference in speeds 
from a combination of cytosolic and rim recoveries is dependent on the rate-limiting 
constant, koff.  Koff is the time it takes for a photobleached protein to detach from a 
subcellular structure before being replaced by a fluorescent protein from the cystolic 
pool or rim.  Since the cytosolic pool of protein is soluble, it is predicted that recovery 
will occur quicker than the lateral movement of recovery along the rim.   If the 
constants between the two recoveries are similar, it could be difficult to separate 
cytosolic from rim recovery.  It is conceivable that a faster acquisition speed could be 
used to identify different recoveries.  




Figure 6: Model depicting lateral and cytosolic recovery of AKAP150-GFP after 
photobleaching.  Cell A depicts cytosolic recovery of AKAP150-GFP in ROI post-
photobleaching.  The recovery in cell A comes from the mobile fraction of 
AKAP150-GFP protein found in the cytosol of LβT2 cells.  Cell B depicts rim 
recovery of AKAP150-GFP in ROI post-photobleaching.  The recovery in cell B 
comes from the mobile fraction of AKAP150-GFP protein found along the rim of 
LβT2 cells.  Cell C depicts simultaneous cytosolic and rim recovery of AKAP150-
GFP in ROI post-photobleaching.  The recovery in cell C comes from the mobile 
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Recovery Curves from LβT2 Cell after FRAP 
 The FRAP experiment verified the mobility of AKAP150-GFP in LβT2 cells; 
however, the mechanism of recovery was not understood.  Thus, further analysis of 
the FRAP data was completed.  The recovery curves in Figures 8A-8C show the 
recovery of fluorescence within inside of the ROI.  The y-axes of the graphs represent 
fluorescence intensity of the AKAP150-GFP protein and the x-axes represent time.  
Figure 8A displays the recovery at the left edge of the ROI.  Figure 8B displays the 
recovery in the middle of the ROI.  Figure 8C displays the recovery of the right edge 
of the ROI.  By comparing the recovery curves along the edges of the ROI to the 
recovery curve at the middle of the ROI, the fluorescence at the middle of the ROI 
takes the longest to recover.  This could be due to the fact that the middle of the ROI 
decreases in fluorescence more than the edges.  This could also result from lateral 
recovery of AKAP150-GFP.  Figure 8D shows the intensity along the entire rim of 
the cell.  The shape of the decrease of intensity in Figure 8D is rectangular.  This is 
the shape that we strive to achieve each time during photobleaching because it 
displays consistent bleaching along the cell rim.  These results demonstrate that 
AKAP150-GFP translocates during recovery.   
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Figure 7: Recovery of AKAP150-GFP inside of the ROI using preliminary 
parameters during FRAP.  Recovery curves were generated from the cell shown in 
Figure 6.  The recovery curves display a change in intensity over time.  (A) Change in 
intensity at the left edge of the ROI.  (B) Change in intensity in the middle of the 
ROI.  (C) Change in intensity at the right edge of the ROI.  (D) Graph showing 
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In addition to measuring the recovery of the area inside of ROI, we examined 
recovery of the rim outside of the ROI.  A loss in fluorescence outside of the ROI 
would provide the most convincing evidence that AKAP150-GFP is mobile.  Figure 
9A measures the change in fluorescence intensity outside of the left edge of the ROI.  
Figure 9B measures the change in fluorescence intensity outside of the right edge of 
the ROI.  The gray line in Figures 9A and 9B mark when photobleaching occurred.  
Fluorescence Loss in Photobleaching (FLIP) occurs on both edges of the ROI.  This 
supports the hypothesis that AKAP150-GFP translocates laterally from the outside of 
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Figure 8:  Fluorescence Loss in Photobleaching (FLIP) in the rim outside of the ROI.  
Preliminary parameters were used for imaging during FRAP.  An area of 0.5 microns 
was measured on each side along the rim outside of the ROI.  Recovery curves were 
generated from the cell shown in Figure 6.  The recovery curves display the change in 
intensity over time.   (A) Change in intensity at the left edge outside of the ROI.  (B) 
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Simulation Heat Maps of Recovery from FRAP 
Simulation heat maps were created to depict changes in fluorescence intensity 
along the cell rim over time (Figure 10).  The simulated data in the heat maps 
demonstrate predicted data.  The heat maps show relative intensity of the cell rim 
over time.   The color red depicts a high intensity, or maximum fluorescence, with a 
value of 1.  The color blue depicts a low intensity, or zero fluorescence, with a value 
of 0.  The x-axis of the heat map represents the cell membrane.  The y-axis of the heat 
map represents time.  The black bars on the heat map show the boundaries of the 
ROI.  The heat map in Figure 10A shows the fluorescence recovery if AKAP150-
GFP recovered only from the cytosol.  The cytosolic recovery appears to have a flat 
base since the rate recovery should be the same along the entire distance of the rim. 
The heat map in Figure 10B is the predicted recovery if AKAP150-GFP recovered 
laterally along the rim.  The shape of the signal is more ovoid and demonstrates that 
the middle of the bleached region is the last to recover.  The heat map in Figure 10C 
is the hypothetical recovery if AKAP150-GFP were to recover from both the cytosol 
and cell rim.  A combination of lateral and cytosolic recovery creates wing-like 
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Figure 9: Simulation heat maps of AKAP150-GFP recovery after FRAP.  The x-axis 
displays distance along the membrane.  The y-axis displays time.  The color red 
indicates a high intensity, or the maximum fluorescence.  The color blue indicates a 
low intensity, or zero fluorescence.  The black bars represent the boundary of 
photobleaching.  The heat map demonstrates (A) Recovery from cytosol.  (B) Lateral 
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Heat Map of LβT2 Cell Recovery after FRAP 
 
A heat map depicting the recovery of AKAP150-GFP from FRAP data was 
plotted to determine if recovery was occurring from the cytosol, rim or both (Figure 
11).  The x-axis represents the distance along the rim of the cell, and the y-axis 
represents time.  The two arrows at the top of the heat map indicate the boundaries of 
the ROI.  The red color at the top of the membrane depicts the first 11 seconds of the 
imaging before bleaching occurred.  The deep blue color after the red portion depicts 
the 5-second bleach.  The rest of the image after the 5-second bleach shows the 
recovery of the cell 314 seconds (5.2 minutes).  Immediately after the cell was 
bleached for 5 seconds, the ROI decreases in fluorescence intensity and remains at a 
decreased intensity over time.  The fluorescence loss in photobleaching outside of the 
ROI indicates that AKAP150-GFP translocates from outside of the ROI to inside of 
the ROI.  This result further supports what we observed Figure 8 and Figure 9.  
Together, these results strongly suggest that AKAP150-GFP translocates laterally 
after photobleaching.  
 While analyzing the heat maps, we noticed spots along the rim (relatively 
distant from the ROI) that changed in fluorescence over time.  The spots showed 
dynamic changes in fluorescence on a much slower time scale than FRAP.  We 
thought that the spots could be the result of over expression of the AKAP150-GFP 
plasmid.  Due to this, we focused on improving temporal resolution rather than 
investigating the nature of the spots.     
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Figure 10: Heat map displaying AKAP150-GFP recovery using preliminary 
parameters during FRAP.  The preliminary parameters were used for imaging during 
FRAP. The x-axis is distance along the membrane.  The y-axis is time.  The black 
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Method Development 
Rapid Photobleaching with Rectangular Regions of Interest 
 Since concluding that AKAP150-GFP is mobile in LβT2 cells, we wanted to 
maximize the capabilities of the confocal microscope to ascertain if we could 
differentiate between cytosolic and rim recoveries.  We determined that a faster 
acquisition speed and decreased photobleach duration were needed in order to detect 
differences between lateral and cytosolic recovery during the fast phases of recovery.  
Since we predicted that recovery from the cytosol is rapid due to availability of 
soluble protein, it was important to bleach for as little time as possible so as to not 
bleach the proteins potentially aiding in recovery.  In addition to increasing 
acquisition speed, we found that a decreased aspect ratio binned pixels in a smaller 
area, allowing for a quicker frame rate.  Using these new parameters, we analyzed 
recovery with the fast rectangle parameters.  We continued to use a rectangular ROI 
because it did not bleach as far into the cytosol as a circular ROI.    
 Two different photobleach time spans were used to examine recovery of 
AKAP150-GFP during FRAP with the fast rectangle parameters.  One photobleach 
time span lasted 1 second.  The other photobleach time span lasted 2.5 seconds.  The 
ROI drawn around the cell in the different time spans was the same size and 
positioned vertically around the rim of one cell, as shown in Figure 6.  When 
comparing bleach time spans at 1 second, it was noticed that there was a lot of 
variability in the extent of ROI was photobleaching (Figures 12A and 12B).  The 
same trend was noticed when comparing the 2.5 second bleach time spans (Figures 
12C and 12D).   In Figure 12B, photobleaching for one second decreased 
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fluorescence intensity to near zero along the entire length of the ROI.  The shape of 
the region photobleached appears as a rectangle.  This is different from Figure 12A, 
where photobleaching with the same settings neither decreased fluorescence intensity 
to the same degree nor photobleached in the shape of a rectangle.  The same trend of 
variation in shape and decreased fluorescence intensity was observed in Figures 12C 
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 Figure 11:  Comparison of ROIs when using fast rectangle parameters during FRAP. 
(A) Cell photobleached for one second.  (B) Cell photobleached for one second. (C) 
Cell photobleached for 2.5 seconds. (D) Cell photobleached for 2.5 seconds.   
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In the process of method development, we treated cells with Rp-8-cpt-cAMPs 
to potentially determine a biological effect of inhibiting protein kinase A.  Figure 13 
measures recovery of a control cell photobleached for one second.  Figure 14 
measures recovery of a cell treated with rp-8-cpt-cAMPs and photobleached for one 
second.  The fast rectangle parameters were used when imaging these cells.  When 
comparing the recovery of the control cell to the drug treated cell after one second of 
photobleaching, it is difficult to perceive a difference.  The recovery curves at the 
edges of the ROI in the control cell recovered instantly (Figures 13A and 13C) 
whereas the recovery curves at the edges of ROI in the rp-8-cpt-cAMPs treated cell 
took more time to recovery (Figures 14A and 14C).  Recovery in the middle of the 
ROI in control cell (Figure 13B) was quicker than in the cell treated with rp-8-cpt-
cAMPs (Figure 14B).  The photobleaching decreased fluorescence shape of a 
rectangle in the cell treated with rp-8-cpt-cAMPs (Figure 14D), but not in the control 
cell (Figure 13D).  This could account for the difference in appearance of the 
recovery curves.  The heat maps also show the difference of the photobleaching 
between the control (Figure 13E) and cell treated with rp-8-cpt-cAMPs (Figure 14E).  
The difference in photobleaching could account for the differences in recovery.  It is 
not yet possible to determine if the difference in recovery was from treatment with rp-
8cpt-cAMPs.  Due to the variability of photobleaching within the ROIs of the control 
and drug-treated cells, it was difficult to interpret the biological significance of the 
results.  
Considering that the results with a one second photobleach were difficult to 
interpret, we decided to compromise speed for greater bleach efficacy.  Figure 15 
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measures recovery of a control cell photobleached for 2.5 seconds.  Figure 16 
measures recovery of a cell treated with rp-8-cpt-cAMPs and photobleached for 2.5 
seconds.  Both cells were imaged using the fast rectangle parameters during FRAP.  
The recovery of the fluorescence of the cell treated with rp-8-cpt-cAMPs (Figure 16) 
was different from that of the control cell (Figure 15).  The recovery curves for the 
outside edges of the ROI in the control cell recover quicker and to pre-bleach 
fluorescence intensity (Figures 15A and 15C).  The recovery curves for the outside 
edges of the ROI in the cell treated with rp-8-cpt-cAMPs show a slower increase in 
fluorescence and do not appear to recover to the pre-bleach fluorescence intensity 
(Figures 16A and 16C).  These same trends were observed in the heat maps (Figures 
15E and 16E).  In both of the heat maps, a small amount of FLIP is observed outside 
of the ROI, indicating lateral recovery.  Similar to the cells photobleached for one 
second using a rectangular ROI, a lot of variability occurred in the photobleaching 
with a 2.5-second time span.  The decrease in fluorescence intensity during 
photobleaching is not as uniform in the control cell (Figure 15D) as the cell treated 
with rp-8-cpt-cAMPs (Figure 16D).  Due to this variability, we could not come to any 
biological conclusions about the effects of treatment with rp-8-cpt-cAMPs.  We did 
conclude that photobleaching for 2.5 seconds produces a consistent decrease in 
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 Figure 12: Recovery of AKAP150-GFP after photobleaching for one second using 
the fast rectangle parameters. (A) Change in intensity at the left edge of the ROI.  (B) 
Change in intensity in the middle of the ROI.  (C) Change in intensity at the right 
edge of the ROI.  (D) Fluorescence intensity along the entire rim of the cell.  (E) Heat 
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 Figure 13: Recovery of AKAP150-GFP treated with rp-8-cpt-cAMPs after 
photobleaching for one second using the fast rectangle parameters. (A) Change in 
intensity at the left edge of the ROI.  (B) Change in intensity in the middle of the 
ROI.  (C) Change in intensity at the right edge of the ROI.  (D) Fluorescence intensity 
along the entire rim of the cell.  (E) Heat map after FRAP.  The black bars show the 
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Figure 14: Recovery of AKAP150-GFP after photobleaching for 2.5 seconds using 
the fast rectangle parameters.  (A) Change in intensity at the left edge of the ROI.  (B) 
Change in intensity in the middle of the ROI.  (C) Change in intensity at the right 
edge of the ROI.  (D) Fluorescence intensity along the entire rim of the cell.  (E) Heat 
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Figure 15: Recovery of AKAP150-GFP treated with rp-8-cpt-cAMPs after 
photobleaching for 2.5 seconds using the fast rectangle parameters. (A) Change in 
intensity at the left edge of the ROI.  (B) Change in intensity in the middle of the 
ROI.  (C) Change in intensity at the right edge of the ROI.  (D) Fluorescence intensity 
along the entire rim of the cell.  (E) Heat map after FRAP.  The black bars show the 
































	   52 
Rapid Photobleaching with Tornado Region of Interest 
 Since using a rectangular region of interest did not provide homogenous 
photobleaching within the ROI, we photobleached more of the cytosol in order to 
achieve more consistent results.  The tool we used to provide a more consistent 
photobleach was the tornado ROI; the settings used during these experiments are 
referred to as fast tornado parameters.  Similar to the data collected when using the 
rectangular ROI, cells were photobleached for either one second or 2.5 seconds.   The 
shape of the tornado ROI was the same size in each of the movies and the location of 
the ROI on each of the cell rims was similar.  Figure 17 measures recovery of a 
control cell after one second of photobleaching.  Figure 18 measures recovery of a 
cell treated with rp-8-cpt-cAMPs after one second of photobleaching.  The decrease 
in fluorescence intensity due to photobleaching is less in the control cell (Figure 17D) 
than in the cell treated with rp-8-cpt-cAMPs.  The recovery curves of the edges and 
middle of the ROI in the control cell look very different from the cell treated with rp-
8-cpt-cAMPs.  In the recovery curve for the left edge of the ROI, recovery occurs 
very quickly and then decreases again.  The same trend is observed in recoveries at 
the right edge and at the middle of the ROI (Figure 17B and 17C).  The recovery 
curve of the left edge of the ROI in the cell treated with rp-8-cpt-cAMPs does not 
appear to decrease in fluorescence intensity, indicating that it was never 
photobleached or recovered as it was photobleached (Figure 18A).  The recovery 
curves of the right edge and middle of the ROI show the same trends (Figure 18C and 
18B).  The recovery curve showing the middle of the ROI in the cell treated with rp-
8-cpt-cAMPs decreases in fluorescence intensity for a longer time than the right edge 
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of the ROI, but then appears to recover quicker (Figure 18D).  However, in the heat 
map of the control cell (Figure 17E), FLIP outside of the ROI is not observed, making 
it difficult to come to a conclusion about the translocation of AKAP150-GFP.  In the 
heat map from the cell treated with rp-8-cpt-cAMPs, (Figure 18E), FLIP does occur 
outside of the ROI, indicating lateral movement of AKAP150-GFP.  Similar to the 
data collected with the fast rectangle parameters, we could not come to any biological 
conclusions about the recovery of AKAP150-GFP due to the inconsistency of 
photobleaching.  Thus, we decided to compromise speed for greater photobleach 
efficacy.  Figure 19 shows recovery of a control cell photobleached for 2.5 seconds.  
Figure 20 shows recovery of a cell treated with rp-8-cpt-cAMPs and photobleached 
for 2.5 seconds.  When comparing the recoveries, it is difficult to determine if there is 
a biological difference with treatment of rp-8-cpt-cAMPs.  The difference could be 
from inconsistent photobleaching.  The decrease of fluorescence intensity during 
photobleaching in the cell treated with rp-8-cpt-cAMPs (Figure 20D) is greater than 
in the control cell (Figure 19D).  Recovery is slowest in the middle of the ROI in the 
control cells, indicating lateral translocation of AKAP150-GFP (Figure 19B).  
Recovery in the cell treated with rp-8-cpt-cAMPs is slower than in the control cell.  
Recovery in the middle of this ROI was the slowest and never recovered to pre-bleach 
fluorescence intensity (Figure 20C).  The differences in fluorescence intensity during 
photobleaching were also observed in the heat maps.  In the cell treated with rp-8-cpt-
cAMPs, the ROI is blue, indicating complete photobleaching of the ROI.  This was 
not observed in the control cell.  Due to the variability of photobleaching, we are not 
yet able to come to a conclusion about the recovery of AKAP150-GFP in cells treated 
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with rp-8-cpt-cAMPs.  Similar to the rectangular ROI, photobleaching for 2.5 seconds 
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Figure 16: Recovery of AKAP150-GFP after photobleaching for one second using the 
fast tornado parameters.  (A) Change in intensity at the left edge of the ROI.  (B) 
Changes in intensity in the middle of the ROI.  (C) Changes in intensity at the right 
edge of the ROI.  (D) Fluorescence intensity along the entire rim of the cell.  (E) Heat 
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Figure 17: Recovery of AKAP150-GFP treated with rp-8-cpt-cAMPs after 
photobleaching for one second with the fast tornado parameters. (A) Changes in 
intensity at the left edge of the ROI.  (B) Changes in intensity in the middle of the 
ROI.  (C) Changes intensity at the right edge of the ROI.  (D) Changes intensity along 
the entire rim of the cell.  (E) Heat map after FRAP.  The black bars show the 
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Figure 18: Recovery of AKAP150-GFP after photobleaching for 2.5 seconds using 
the fast tornado parameters. (A) Changes in intensity at the left edge of the ROI.  (B) 
Changes in intensity in the middle of the ROI.  (C) Changes in intensity at the right 
edge of the ROI.  (D) Fluorescence intensity along the entire rim of the cell.  (E) Heat 
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Figure 19: Recovery of AKAP150-GFP after treated with rp-8-cpt-cAMPs and 
photobleaching for 2.5 seconds using the fast tornado parameters. (A) Changes in 
intensity at the left edge of the ROI.  (B) Changes in intensity in the middle of the 
ROI.  (C) Changes in intensity at the right edge of the ROI.  (D) Fluorescence 
intensity along the entire rim of the cell.  (E) Heat map after FRAP.  The black bars 
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Since the extent of photobleaching showed substantial variability, we 
compared the intensity profiles of the tornado ROIs (Figure 21) to verify that the 
decrease in fluorescence intensity produced by each ROI was different.  In theory, the 
decrease in fluorescence intensity from photobleaching for 2.5 seconds should be 
greater than photobleaching for one second.  The size of each ROI in Figure 21 is the 
same with the exception of the ROI represented by the red profile.  This ROI 
represented by the red profile was slightly smaller.  The decrease in fluorescence 
intensity was not uniform when photobleaching for either one second or 2.5 seconds.  
Under the same conditions, photobleaching for one second or 2.5 seconds yields the 
same decrease in fluorescence intensity.  Photobleaching for the same amount of time 
yields different decreases in fluorescence intensity. The two profiles with the largest 
decrease fluorescence intensity were photobleached for different times; one was 
photobleached for one second and the other photobleached for the 2.5 seconds.  The 
shape created by the decrease in fluorescence intensity shown with the ROIs 
represented by the red and black profiles was what we aimed to achieve during each 
photobleach.  We are now aware we can achieve this shape, but are unsure of how to 
consistently achieve it.    
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Figure 20: Comparison of intensity profiles during photobleaching using the fast 
tornado parameters.  The size of the ROI was the same in each profile with the 
exception of the ROI designated by the red line, which used a slightly smaller ROI. 
The profiles labeled as Control are control cells.  Profiles labeled as Drug are cells 
treated with rp-8-cpt-cAMPs.  Control 9 was photobleached for one second.  Control 
10, was photobleached for 2.5 seconds.  Drug 10 was photobleached for 2.5 seconds.  
Drug 11 was photobleached for one second.  Drug 12 was photobleached for 2.5 
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Immunostaining of Endogenous AKAP150 and Actin 
 To determine if the spots were a result of over expression of AKAP150-GFP, 
control LβT2 cells were immunostained for endogenous AKAP150 and actin (Figure 
23).  Endogenous AKAP150 staining revealed a rim composed of spots, verifying that 
the spots are not a result of over expression.  Cells immunostained with endogenous 
AKAP150 were treated with rp-8-cpt-cAMPs or 6-benzoyl-cAMP.   When comparing 
rim brightness in the control, rp-8-cpt-cAMPs-treated and 6-benzoyl-cAMP-treated 
cells, it is difficult to identify a differnce.  When comparing the rim brightness of 
actin in the control, rp-8-cpt-cAMPs-treated and 6-benzoyl-cAMP-treated cells, the 
actin treated with rp-8-cpt-cAMPs appears brightest.  We did not make any intensity 
measurements on the spots.  The appearance of increased brightness was determined 
by how they appeared to us.  There is a similarity between the bright spots on the 
cells immunostained for AKAP150 and actin, suggesting that AKAP150 and actin are 
localized in the same areas.   
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Figure 21: Immunostaining of endogenous AKAP150 and actin.  Cells were fixed, 
permeabilized and immunostained for AKAP150 and actin.  Cells were imaged using 
a laser scanning confocal microscope.  AKAP150 was imaged with the Alexa 488 
laser with 5% transmission.  Actin was imaged with the Alexa 568 laser set to 5% 
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To analyze whether there was a statistically significant difference in 
fluorescence intensity between control cells and cells treated with rp-8-cpt-cAMPs 
and 6-benzoyl-cAMP, a students’s t-test was used.  In addition to the t-test, dot plot 
graphs were created to demonstrate the normal distribution and median of 
fluorescence intensity (Figure 24).  There is a significant difference in AKAP150 
fluorescence intensity between the control cells and the cells treated with rp-8-cpt-
cAMPs.  There is also a significant difference in AKAP150 fluorescence intensity 
between the control cells and the cells treated with 6-benzoyl-cAMP.  In both results, 
AKAP150 decreased fluorescence intensity after treatment with the pharmacological 
agent.  It was not the same case with actin. There is a significant difference in actin 
fluorescence intensity between control cells and cells treated with 6-benzoyl-cAMP, 
but not in cells treated with rp-8-cpt-cAMPs.    
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Figure 22: Comparison endogenous AKAP150 rim brightness in cells treated with rp-
8-cpt-cAMPs or 6-benzoyl-cAMP.  Cells were imaged on a scanning laser confocal 
microscope.  Control cells N= 24, Cells treated with rp-8-cpt-cAMPs N=10, Cells 
treated with 6-benzoyl-cAMP N=18.  Cells were imaged using the same settings as 
the endogenous staining.  Statistics: Student t-test between control cells and cells 
treated with rp-8-cpt-cAMPs, p=0.025.  Student t-test between control cells and cells 
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Figure 23: Comparison of actin rim brightness in cells treated with rp-8-cpt-cAMPs 
or 6-benzoyl-cAMP.  Cells were imaged on a scanning laser confocal microscope.  
Cells were analyzing by drawing masks on the fluorescent rims and subtracting 
background.  Control cells N= 24, Cells treated with rp-8-cpt-cAMPs=10, Cells 
treated with 6-benzoyl-cAMP N=18.  Cells were imaged using the same settings as 
the endogenous staining.  Statistics: Student t-test between control cells and cells 
treated with rp-8-cpt-cAMPs, p=0.464.  Student t-test between control cells and cells 
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Permeabilization Assay in Transfected LβT2 Cells 
 
Seeing that the rims of the LβT2 cells stained for endogenous AKAP150 had 
a more puncta appearance than the cells transfected with AKAP150-GFP, we 
wondered if permeabilization was causing AKAP150 to disappear.  If AKAP150 was 
binding to lipids in the cell membrane, it is possible that the holes created by Triton 
X-100 during permeabilization were causing AKAP150 to leave the rim.  Cells were 
permeabilized after fixation, but before the addition of DAPI. Images of cells 
permeabilized or non-permeabilized were compared to demonstrate differences in rim 
appearance (Figure 25). The cells in Figure 25A had intact rims and the cells in 
Figure 25B were permeabilized.  There was a difference in the appearance of the rim 
when comparing the intact to the permeabilized cell rim.  The rim of the cell 
permeabilized exhibits a slight increase in puncta appearance, but it does not look 
similar to endogenous rim staining of AKAP150.  The changes in fluorescence 
intensity were compared using a dot plot illustrating the distribution and median of 
the data (Figure 26).  While there was a significant statistical difference in rim 
brightness, the non-normal distribution is mostly likely caused by transient nature of 
transfection.  Each cell does not over-express the same amount of AKAP150-GFP 
during a transfection, leading to a non-normal distribution of fluorescence intensity.  
Based on these results, we concluded that the AKAP150 endogenous staining pattern 
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Figure 24: Comparison of rims from intact and permeabilized LβT2 cells transfected 
with AKAP150-GFP.  Non-permeabilized (intact) cells were fixed after transfection 
with AKAP150-GFP.  Permeabilized cells treated with Triton X-100 before fixation. 
A" B"
9μm$9μm$
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Figure 25:  Comparison of rim brightness from intact and permeabilized LβT2 cells 
transfected with AKAP150-GFP.  Non-permeabilized (intact) cells were fixed after 
transfection with AKAP150-GFP.  Permeabilized cells treated with Triton X-100 
before fixation.  Non-permeabilized cells: N=65, median intensity: 58.472.  
Permeabilized cells: N=46, median intensity: 42.987.  Statistics: Wilcoxon-Rank-Sum 










From our experiments we conclude that AKAP150-GFP is mobile in LβT2 
cells and it appears to move laterally along the rim.  The mobility of AKAP150-GFP 
was demonstrated in the time-lapse (Figure 4) and FRAP (Figure 11) assays.  The 
decrease in fluorescence intensity in most observed of the cells treated with 
pharmacological agents in the time lapse assays suggests that AKAP150-GFP was 
mobile.  As a more sensitive system in which to examine the translocation of 
AKAP150-GFP, we analyzed the mobility of AKAP150-GFP using FRAP.  Heat 
maps created from the FRAP data provided evidence that AKAP150-GFP moved 
laterally along the cell rim.  Not only did the heat maps show recovery within the 
ROI, the maps demonstrate FLIP outside of the ROI.  The fluorescence loss in 
photobleaching outside of the ROI shows that AKAP150-GFP translocates laterally 
from outside of the ROI to inside of the ROI during recovery (Figure 9).   Results 
supporting lateral mobility were also observed in the recovery curves.  In almost all 
of the recovery curves, the middle of the ROI recovered slower than the edges of the 
ROI.   
The recovery of AKAP150-GFP could be affected by the higher expression of 
endogenous AKAP150 and actin within the spots observed in cells immunostained 
for AKAP150 and actin (Figure 23).  The biological nature of the spots is not yet 
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known.  It is possible that the spots provide a barrier or sink to lateral and cytosolic 
movement during recovery.  It is possible that AKAP150 must first bind to the spots 
before continuing translocation during recovery.  When comparing the profile 
fluorescence intensities of AKAP150 to actin, it appears to be similar.  This suggests 
that AKAP150 could be bound (directly or indirectly) to actin in LβT2 cells.  The 
significant decrease in AKAP150 fluorescence intensity in cells treated with rp-8-cpt-
cAMPs or 6-benzoyl-cAMP suggests a change in localization of the scaffolding 
protein upon the activation or inhibition of PKA (Figure 24).  The significant 
decrease in actin fluorescence intensity in cells treated with 6-benzoyl-cAMP could 
be occurring due to actin remodeling.  In pancreatic β cells, filamentous actin is 
remodeled before secretion of insulin (Kalwat and Thurmond 2013).  
When contemplating how mobility of AKAP150 impacts signaling in LβT2 
cells, it is feasible that it adds another level of negative feedback.  By removing PKA 
from its target protein, AKAP150 inhibits the possibility of erroneous, activating 
phosphorylation.  A different way that the mobility of AKAP150 impacts signaling is 
through signaling cascades.  It is imaginable that the scaffolding protein is involved 
with multiple different signaling cascades.  Translocating to different areas in the cell 
would allow AKAP150 to participate in several pathways.  In specific areas of the 
cell, AKAP150 could bind different enzymes.  This would allow AKAP150 to create 
different changes in the cell based on localization. 
While the scanning laser confocal microscope provided conclusive results 
using the preliminary parameters, we realized increasing temporal resolution is more 
challenging than anticipated.  In order to minimize photobleaching in the cytosol, the 
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fast rectangular parameters were used during FRAP (Figure13- Figure 16).  We 
predicted this would allow us to identify a difference between cytosolic and lateral 
recovery.  After several FRAP experiments, we realized that the ROI was not 
uniformly photobleached (Figure 12).  Increasing the amount of time photobleached 
from one second to 2.5 seconds did improve in decreasing fluorescence intensity, but 
not consistency.  Deciding to forgo cytosolic photobleaching in favor of a more 
consistent decrease in fluorescence intensity, the fast tornado parameters were used 
during FRAP (Figure 17- Figure 20).  Similar to the fast rectangular parameters 
results, there was inconsistency in the photobleaching when using a tornado ROI.  
Increasing photobleaching from one second to 2.5 second did improve in decrease 
fluorescence intensity, but not consistency.  These results were substantiated when 
viewing the tornado ROI intensity profiles (Figure 21).  The scanning laser confocal 
microscope does not provide consistent photobleaching when using the fast rectangle 
parameters or the fast tornado parameters.  Due to inconsistency during 
photobleaching, the average shape of the ROI is different from what would be ideal 
(Figure 22).  The ideal shape during photobleaching is rectangular, as shown in the 
red and black intensity profiles in Figure 21.  In analyzing data collected from the fast 
rectangle parameters and the fast tornado parameters, we came to the conclusion that 
out of the several FRAP movies collected, only a few were useful.  The best way to 
collect data from the fast rectangle or tornado parameters might be to take several 
FRAP videos and only use the results have a rectangular shaped intensity profile.  It is 
possible that the scanning laser confocal microscope can only produce an adequate 
decrease in fluorescence intensity when photobleaching for 2.5 seconds.      
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Future Directions 
 Since the trend of decreased intensity was observed in almost all of the 
pharmacological agents used in the time-lapse imaging assays, we want to examine 
these results further.  In order to accomplish this, we will use all of the 
pharmacological agents in the time-lapse assay during FRAP.  Before this can be 
done, we must determine the best way to collect FRAP data.  One possibility is 
changing the shape of the ROI while using the fast tornado parameters.  By increasing 
the size of the ROI, it is possible to consistently create a rectangular-shaped 
photobleach, similar to the black intensity profile in Figure 21.  Although this would 
be at the expense of photobleaching more cytosol, we decided it more beneficial to 
have a consistent ROI.  If we could photobleach with the same shaped ROI, we could 
continue to push temporal resolution.  This would allow us to examine recovery after 
only one second of photobleaching.   
 Another future direction is focusing on, identifying and finding the 
significance of the spots in the endogenous AKAP150 staining.  By treating the cells 
with all of the pharmacological agents used in the time-lapse imaging assay, we can 
compare changes in AKAP150 and actin intensities.  This would allow us to 
determine if the AKAP150 and actin intensities continue to appear to change 
together.  These results could help in determining if AKAP150 attaches (directly or 
indirectly) to actin.  Taking videos of transfected cells without photobleaching will 
show what is happening to the spots over time.  We could determine if the spots 
change intensity without photobleaching and calculate their recovery rate.  Then we 
could determine if rate of change in the spots is different during photobleaching.   
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 Lastly, we are interested in the changes in cytosolic calcium after treatment 
with the pharmacological agents in the time-lapse imaging assay.  This can be 
investigated using FURA2-AM in cells transfected with AKAP150-GFP.  An 
increase in cytosolic calcium can indicate the opening of ion channels, leading to the 
secretion of hormone.  If we could determine which pharmacological agents 
potentially cause opening of ion channels, we could learn more about what causes the 
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